BCL-X(L)-regulated apoptosis in T cell development

International Immunology

Volumn 9, Issue 9, 1997, Pages 1375-1384

  Chao, Debra T ^a   Korsmeyer, Stanley J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

TCR; Thymus; Transgenic

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR; BCL2L1 PROTEIN, HUMAN; BCL2L1 PROTEIN, MOUSE; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL X;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRESSOR GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE; TRANSGENE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; CYTOLOGY; DOWN REGULATION; GENE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DOWN-REGULATION; GENES, RAG-1; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, SCID; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 0030610288     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.9.1375     Document Type: Article

References (51)

1. Sprent, J. 1993. T lymphocytes and the thymus. In Paul, W., ed., Fundamental Immunology, p. 75. Raven Press, New York
2. Von Boehmer, H. 1994. Positive selection of lymphocytes. Cell 76:219.
3. Nossal, G. J. V 1994. Negative selection of lymphocytes. Cell 76:229.
4. Williams, G. T. and Smith, C. A. 1993. Molecular regulation of apoptosis: genetic control on cell death. Cell 74:777.
5. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B. and Korsmeyer, S. J. 1995. Bcl-2 family members demonstrate selective, competing dimerizations. Proc. Natl Acad. Sci. USA 92:7834.
6. Yang, E. and Korsmeyer, S. J. 1996. Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood 88:386.
7. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. C. and Fesik, S. W. 1996. X-ray and NMR structure of human BCL-X(L), an inhibitor of programmed cell death. Nature 381:335.
8. Yin, X-M, Oltvai, Z. N. and Korsmeyer, S. J. 1994. BH1 and BH2 domains of BCL-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321.
9. L. Nature 379:554.
10. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1:197.
11. Veis, D., Sorenson, C. M., Shutter, J. R. and Korsmeyer, S. J. 1993. BCL-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229.
12. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S. J, 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879.
13. Strasser, A., Harris, A. W. and Cory, S, 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889.
14. + thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus. J. Exp. Med. 179:145.
15. Boise, L. H., Gonzalea-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G. and Thompson, C. B. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597.
16. Ma, A., Pena, J. C., Chang, B., Margosian, E., Davidson, L., Alt, F, W. and Thompson, C. B. 1995. Bcl-x regulates the survival of double-positive thymocytes. Proc. Natl Acad. Sci. USA 92:4763.
17. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182:1973.
18. Veis, D. J., Sentman, C. L., Bach, E. A. and Korsmeyer, S. J. 1993. Expression of the BCL-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:2546
19. Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S. and Loh, D. Y. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x deficient mice. Science 267:1506.
20. Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B. and Korsmeyer, S. J. 1995. Bcl-xL and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:821.
21. L. Immunity 3:87.
22. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746.
23. Vasquez, N. J., Kaye, J. and Hedrick, S. M. 1992. In vivo and in vitro clonal deletion of double-positive thymocytes. J. Exp. Med. 175:1307.
24. Crispe, I. N. and Bevan, M. J. 1987. Expression and functional significance of the J11d marker on mouse thymocytes. J. Immunol. 138:2013.
25. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S. and Papaioannou, V. E. 1992. Rag-1-deficient mice have no mature B and T lymphocytes. Cell 68:869.
26. - thymocytes. Eur. J. immunol. 21, 835.
27. Fowlkes, B. J. and Pardoll, D. M. 1989. Molecular and cellular events of T cell development. Adv. Immunol. 44:207.
28. Robey, E. A., Fowlkes, B. J., Gordon, J. W., Kioussis, D., von Boehmer, H., Ramsdell, F. and Axel, R. 1991. Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CDS lineage. Cell 64:99.
29. Chan, S. H., Cosgrove, D., Waltzinger, C., Benoist, C. and Mathis, D, 1993. Another view of the selective model of thymocyte selection. Cell 73:225.
30. Davis, C. B., Kileen, N., Crooks, M. E. C., Raulet, D. and Litterman, D. R. 1993. Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes. Cell 73:237.
31. + T cell lineages: a new perspective on thymic commitment and selection. Immunity 2:413.
32. hi thymocytes. J. Exp. Med. 181:1643.
33. Strasser, A., Harris, A. W., Corcoran, L. M. and Cory, S. 1994. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 368:457.
34. Blunt, T., Finnie, N. J., Taccioli, G. E., Alt, F. W., Jeggo, R A. and Jackson, S. P. 1995. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation Cell 80:813.
35. Kirchgessner. C. U., Patil, C. K., Evans, J., Cuomo, C. A., Fried, L. M., Carter, T. Oettinger, M. and Brown, J. M. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178.
36. Eastman, Q. M., Leu, T. M. J. and Schatz, D. 1996. Initiation of V(D)J recombination in vitro obeying the 12/23 rule. Nature 380:85.
37. Gallo, M. L., Pergola, F., Daniels, G. A. and Lieber, M. R. 1994. Distinct roles for RAG-1 in the initiation of V(D)J recombination and in the resolution of coding ends. J. Biol. Chem. 269:22188.
38. Danska, J. S., Pflumio, F., Williams, C. J., Huner, O., Dick, J. and Guidos, C. 1994. Rescue of T cell-specific V(D)J recombination in scid mice by DNA-damaging agents. Science 266:450.
39. Murphy, W. J., Durum, S. K., Anver, M. R., Ferris, D. K., McVicar, D. W., O'Shea, J. J., Ruscetti, S. K., Smith, M. R., Young, H. A. and Longo, D. L. 1994. Induction of T cell differentiation and lymphogenesis the thymus of mice with severe combined immune deficiency (SCID), J. Immunol. 153:1004.
40. + thymocytes in RAG-deficient mice through a T cell receptor β chain-independent pathway. J. Exp. Med. 181:1187.
41. + thymocytes without T cell receptor β rearrangement in recombinase activation gene 2-/- mice. J. Exp. Med. 180:1517.
42. Bogue, M. A., Zhu, C., Agular-Cordova, E., Donehower, L. A. and Roth, D. B. 1996. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10:553.
43. Guidos, C. J., Williams, C. J., Grandal, I., Knowles, G., Huang, M. T. F. and Danska, J. S. 1996. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10:2038.
44. Nacht, M., Strasser, A., Chan, Y. R., Harris, A. W., Schlissel, M. Bronson, R. T. and Jacks, T. 1996. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10:2055.
45. +) thymocytes in normal and genetically modified mice. J. Immunol. 95:5103.
46. Mombaert, P., Clarke, A. R., Rusinicki, M. A., Iacomini, J., Itohara, S., Lafaille, J. J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M. L. and Tonegawa, S. 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360:225.
47. Mombaerts, P., Anderson, S. J., Perlmutter, R. M., Mak, T. W. and Tonegawa, S. 1994. An activated lck transgene promotes thymocytes development in RAG-1 mutant mice. Immunity 1:261.
48. Mazel, S., Burtrum, D. and Petrie, H. T. 1996. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183:2219.
49. Linette, G. P., Li, Y., Roth, K. and Korsmeyer, S. J. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl Acad. Sci. USA 93:9545.
50. O'Reilly, L. A., Huang, D. C. S. and Strasser, A. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:6979.
51. Gino, V., Innes, K. M. and Adams, J. M. 1996. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13:1511.